SEC Filing Details

Document Details

Form
Filing Date
May 17, 2017
Document Date
May 16, 2017
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
G1 Therapeutics, Inc.
Issuer
G1 Therapeutics, Inc.
Filer
MedImmune Ventures, Inc.